Myocardial densification insufficiency is generally not self-curable because it is a lifelong disease and presents with progressive heart failure, malignant arrhythmia and thromboembolism. 1. Progressive heart failure: lesions involving the…
There is no targeted treatment for myocardial densification insufficiency, which is mainly for heart failure and arrhythmia, including drug antihypertensive treatment and surgical transplantation treatment. 1. Drug therapy: Due to…
Cardiac densification insufficiency may cause weakness in the extremities. Myocardial densification insufficiency is a cardiomyopathy. It is characterized by the presence of abnormally large myofibrillar trabeculae and interlocking deep saphenous…
Myocardial densification insufficiency is not a terminal disease and can last for many years asymptomatically, but it can also lead to severe heart failure and death at an early stage,…
Introduction Noncompaction of the Ventricular Myocardium (NVM) is currently considered to be a cardiomyopathy caused by arrested development of the endocardium and myocardial layer during embryonic development, often in conjunction with…
Noncom paction of ventricular myocardium (NVM) is a rare congenital myocardial disorder that is characterized by a failure of reticular myocardium densification during early embryonic development, resulting in the persistence…
Noncompaction of the ventricular myocardium is a rare congenital cardiac malformation due to failure of myocardial densification during embryogenesis, characterized anatomically by excessive protrusion of myocardial trabeculae in the ventricular…
Myocardial densification insufficiency, also known as left ventricular densification insufficiency, left ventricular high trabeculation, or spongy myocardium. Normal densification of the lax reticular structures of the ventricular myocardium occurs…